Tag: Virology
-
How Tiny RNA Helpers in Phages Boost Bacterial Hijacking and Phage Replication
Introduction: A Tiny RNA, Big Impact As antibiotic resistance climbs, scientists are turning to bacteriophages—viruses that infect bacteria—as potential allies in the fight against hard-to-treat infections. A recent study uncovers a surprising mechanism: phages use a small RNA molecule to hijack bacterial cells, rewiring their machinery to favor phage replication. This discovery adds a new…
-
From Arauca to the World: Meet the Colombian Scientist Fighting the Next Pandemic
Rising from Arauca: A scientist’s unlikely journey In the heart of Colombia, a small town and a region long marked by conflict and resilience has produced a scientist now at the forefront of global health. This is the story of a researcher who grew up amid challenging circumstances, endured displacement, and turned those experiences into…
-
Tracing Patient Zero: The SARS Outbreak and the Older Cousin of COVID
Introduction: A Mysterious Pneumonia and the First Clues In November 2002, a cluster of unusual pneumonia cases appeared in Guangdong, China, puzzling clinicians and public health officials. These infections would soon be recognized as the early chapters in the SARS saga, a disease caused by the SARS coronavirus (SARS-CoV). Long before the world grappled with…
-
Could a Common Virus Be Behind All Lupus Cases? New Study Sparks Debate
Overview: A Potential Common Trigger for Lupus Researchers are examining a provocative idea: could a single, widespread virus be the root cause of lupus across diverse populations? A recent study suggests that one of the world’s most common viruses may play a central role in triggering the autoimmune disease known as lupus. While the finding…
-
Common virus may link to all lupus cases — study finds
New insight on lupus: a single virus may underlie all cases In a development that could reshape the understanding of lupus, researchers say a common virus might be the shared trigger behind the autoimmune disease. The study, published this week, proposes that a single viral factor could be linked to the wide range of symptoms…
-
Could a Common Virus Explain All Lupus Cases? New Study Sparks Debate
New findings propose a unifying trigger for lupus A recent study is drawing attention in the medical community by proposing that a widespread virus might be the common trigger behind lupus, an autoimmune disease known for its broad array of symptoms. While the report has not settled the debate about lupus’s origins, it adds a…
-
Genezen and Humane Genomics Announce Manufacturing Partnership to Advance Pediatric Liver Cancer Therapy
Overview of the Partnership Genezen, a leading viral vector CDMO, and Humane Genomics, a biotechnology company focused on oncolytic viral therapies, have unveiled a strategic manufacturing partnership aimed at accelerating the development and production of innovative treatments for pediatric liver cancer. The collaboration combines Genezen’s deep expertise in scale-ready viral vector manufacturing with Humane Genomics’…
-
Bats and Dangerous Viruses: New Insights from Nature
Introduction: Rethinking Bat-Virus Relationships A recent study published in Nature Communications Biology offers a fresh perspective on how bats interact with dangerous viruses. Led by researchers at the University of Oklahoma, the work challenges some long-held assumptions about bats as universal reservoirs for high-risk pathogens. Instead, the study emphasizes context, behavior, and ecology as key…
-
Pin1 Inhibitors Offer New Hope Against Cold Sores by Altering Cell Structures
New class of antivirals targets host cell structure to block HSV-1 A promising development from recent research suggests that a class of antivirals known as Pin1 inhibitors could prevent or significantly reduce outbreaks of herpes simplex virus 1 (HSV-1), the virus behind oral herpes and cold sores. The study, published in Antiviral Research, highlights a…
-
Pin1 Inhibitors Could Halt HSV-1 Outbreaks In Humans
New Pin1 Inhibitors Offer a New Way to Combat Cold Sores Researchers are exploring a novel class of antivirals that could change how we prevent and treat oral herpes. Pin1 inhibitors, designed to target a cellular enzyme called peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 (Pin1), have shown potential to curb herpes simplex virus 1 (HSV-1) replication.…